Furthermore, in microarray-based datasets of gliomas, pancreatic tumors, melanomas, and gastric cancers, we identified a correlation between the poor survival rates of the four patient groups and high expression levels of COL4A1. The gene discussed is COL4A1; the disease is melanoma.